Evidence map›Paper›PMID 40787526›Full record

ReviewAnnals of medicine and surgery (2012)2025

Radical nephrectomy vs. partial nephrectomy in T1-2, N0, M0 cystic renal cell carcinoma.

Marco Braaten, Bob Weng, Reid Morrissey, Muhammad Sohaib Asghar, Peter Silberstein, Ali Bin Abdul Jabbar, Tauseef Abubakar, Mohsin Mirza

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marco BraatenCreighton University Department of Internal Medicine, CHI Health Bergan Mercy Hospital, Omaha, Nebraska, USA.
Bob WengCreighton University Department of Internal Medicine, CHI Health Bergan Mercy Hospital, Omaha, Nebraska, USA.ORCID https://orcid.org/0009-0003-0859-7251
Reid MorrisseyCreighton University Department of Internal Medicine, CHI Health Bergan Mercy Hospital, Omaha, Nebraska, USA.
Muhammad Sohaib AsgharMayo Clinic, Rochester, Minnesota, USA.
Peter SilbersteinCreighton University Department of Hematology & Oncology, CHI Health Bergan Mercy Hospital, Omaha, Nebraska, USA.
Ali Bin Abdul JabbarCreighton University Department of Internal Medicine, CHI Health Bergan Mercy Hospital, Omaha, Nebraska, USA.
Tauseef AbubakarCreighton University Department of Internal Medicine, CHI Health Bergan Mercy Hospital, Omaha, Nebraska, USA.
Mohsin MirzaCreighton University Department of Internal Medicine, CHI Health Bergan Mercy Hospital, Omaha, Nebraska, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evaluate survival outcomes of PN compared to RN in patients with T1-2, N0, M0 cRCC. Methods: Patients with cRCC were identified using the National Cancer Database (NCDB). Inclusion criteria included T1-2, N0, M0 disease, treatment with either PN or RN, and a Charleston Deyo co-morbidity score of 0. Patients with missing survival data, advanced staging, or incomplete surgical information were excluded. Propensity score matching was performed to create identical groups with respect to age, sex, and race. Kaplan-Meier survival curves, multinomial logistic regression, and cox proportional hazard models were used for statistical analysis. Results: Of the 476 eligible propensity matched patients, 238 (50.0%) underwent PN and 238 (50.0%) underwent RN. PN was associated with better survival (mean: 186 vs. 170 months, Conclusion: Partial nephrectomy demonstrates superior survival and shorter hospital stays compared to radical nephrectomy in localized cRCC, reinforcing its role as the preferred surgical approach.

Identifiers

PMID40787526
PMCPMC12333707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.